Exicure, Inc. (XCUR) stock
XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$1.08+0.01 (+0.93%)
Close on Nov 17, 2026Market cap $7.07MP/E –Yield –
Exicure ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Exicure's ebitda for the twelve months ending Jun 30, 2026 was -$7.14M. For fiscal 2025 it was -$3.99M. The highest annual figure on record is -$668.00K in fiscal 2022.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$3.99M | – |
| FY2024 | Dec 31, 2024 | -$12.20M | – |
| FY2023 | Dec 31, 2023 | -$14.36M | – |
| FY2022 | Dec 31, 2022 | -$668.00K | – |
| FY2021 | Dec 31, 2021 | -$61.43M | – |
| FY2020 | Dec 31, 2020 | -$24.67M | – |
| FY2019 | Dec 31, 2019 | -$26.23M | – |
| FY2018 | Dec 31, 2018 | -$21.46M | – |
| FY2017 | Dec 31, 2017 | -$10.18M | – |
| FY2016 | Dec 31, 2016 | -$15.98M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.01M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.59M | -153.3% |
| Q4 FY2025 | Dec 31, 2025 | -$2.23M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.31M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.44M | – |
| Q1 FY2025 | Mar 31, 2025 | $2.98M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.58M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.57M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.23M | – |
| Q1 FY2024 | Mar 31, 2024 | -$829.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.49M | -107.9% |
| Q3 FY2023 | Sep 30, 2023 | -$3.17M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.41M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.29M | – |
| Q4 FY2022 | Dec 31, 2022 | $18.88M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.92M | – |
| Q2 FY2022 | Jun 30, 2022 | -$7.19M | – |
| Q1 FY2022 | Mar 31, 2022 | -$7.44M | – |
| Q4 FY2021 | Dec 31, 2021 | -$13.16M | – |
| Q3 FY2021 | Sep 30, 2021 | -$22.80M | – |
| Q2 FY2021 | Jun 30, 2021 | -$13.58M | – |
| Q1 FY2021 | Mar 31, 2021 | -$11.89M | -1844.0% |
| Q4 FY2020 | Dec 31, 2020 | -$12.19M | – |
| Q3 FY2020 | Sep 30, 2020 | -$8.96M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.20M | – |
| Q1 FY2020 | Mar 31, 2020 | $682.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$9.98M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.86M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.90M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.49M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.78M | – |
| Q3 FY2018 | Sep 30, 2018 | -$5.77M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.71M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.20M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.24M | – |
| Q4 FY2016 | Dec 31, 2016 | -$5.40M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.22M | – |
See a number that looks wrong?